Bosentan alleviates the pro-fibrotic phenotype of lung scleroderma fibroblasts: Implications for treatment of scleroderma.

Bosentan alleviates the pro-fibrotic phenotype of lung scleroderma fibroblasts: Implications for treatment of scleroderma.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Leask, A, Xu, S, Renzoni, E, Bou-Gharios, G, du Bois, R, Abraham, D, Black, C
Μορφή:	Conference item
Έκδοση:	2005

Παρόμοια τεκμήρια

Bosentan attenuates the profibrotic gene expression profile of lung fibroblasts in scleroderma
ανά: Shiwen, X, κ.ά.
Έκδοση: (2006)

Effects of bosentan on collagen type I synthesis on in vitro culture of scleroderma skin fibroblasts
ανά: S. Soldano, κ.ά.
Έκδοση: (2011-01-01)

Successful Treatment with Bosentan of Lower Extremity Ulcers in a Scleroderma Patient
ανά: Alix Naert, κ.ά.
Έκδοση: (2013-01-01)

CTGF overexpressing mice: a model for human scleroderma
ανά: Sonnylal, S, κ.ά.
Έκδοση: (2006)

Bosentan Does Not Affect Renal Resistive Index in Scleroderma/Systemic Sclerosis Patients
ανά: Emma Di Poi, κ.ά.
Έκδοση: (2023-11-01)

Scleroderma with Nodular Scleroderma
ανά: Chutika Srisuttiyakorn, κ.ά.
Έκδοση: (2016-11-01)

Endogenous endothelin-1 signaling contributes to type I collagen and CCN2 overexpression in fibrotic fibroblasts.
ανά: Shi-Wen, X, κ.ά.
Έκδοση: (2007)

Endothelin-1 promotes myofibroblast induction through the ETA receptor via a rac/phosphoinositide 3-kinase/Akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts.
ανά: Shi-Wen, X, κ.ά.
Έκδοση: (2004)

Scleroderma and scleroderma-like syndromes
ανά: Katarzyna Romanowska-Próchnicka, κ.ά.
Έκδοση: (2024-06-01)

Corrigendum: Scleroderma and Scleroderma-like syndromes
ανά: Katarzyna Romanowska-Próchnicka, κ.ά.
Έκδοση: (2024-07-01)

Paraneoplastic scleroderma or neoplasia secondary to scleroderma
ανά: Alexandru Arvunescu, κ.ά.
Έκδοση: (2019-12-01)

Antifibrotic effects of roscovitine in normal and scleroderma fibroblasts.
ανά: Richard A Steinman, κ.ά.
Έκδοση: (2012-01-01)

Checkpoint Inhibitor-Associated Scleroderma and Scleroderma Mimics
ανά: Michael Macklin, κ.ά.
Έκδοση: (2023-02-01)

Use of Patterned Collagen Coated Slides to Study Normal and Scleroderma Lung Fibroblast Migration
ανά: Bahja Ahmed Abdi, κ.ά.
Έκδοση: (2017-06-01)

Scleroderma as a paraneoplastic syndrome and tumors associated with scleroderma
ανά: N. A. Shostak, κ.ά.
Έκδοση: (2020-05-01)

Keloids in scleroderma-keloidal scleroderma: A unique entity
ανά: Sumit Sen, κ.ά.
Έκδοση: (2013-01-01)

The Anti-Fibrotic Effect of Cold Atmospheric Plasma on Localized Scleroderma In Vitro and In Vivo
ανά: Stephanie Arndt, κ.ά.
Έκδοση: (2021-10-01)

Intramuscular Polydeoxyribonucleotides in Fibrotic and Atrophic Localized Scleroderma: An Explorative Prospective Cohort Study
ανά: Maurizio Romagnuolo, κ.ά.
Έκδοση: (2023-04-01)

Genetics of scleroderma: implications for personalized medicine?
ανά: Assassi Shervin, κ.ά.
Έκδοση: (2013-01-01)

Mimics of scleroderma
ανά: Kaveri K Nalianda, κ.ά.
Έκδοση: (2017-01-01)

The pathogenesis of scleroderma
ανά: Latika Gupta, κ.ά.
Έκδοση: (2017-01-01)

Rac inhibition reverses the phenotype of fibrotic fibroblasts.
ανά: Shi-wen Xu, κ.ά.
Έκδοση: (2009-10-01)

Response of human lung fibroblast cells to stimulation by endothelin-1: Involvement of ras/MEK/ERK and PI3 kinase
ανά: Shiwen, X, κ.ά.
Έκδοση: (2003)

Endothelin is a downstream mediator of profibrotic responses to transforming growth factor beta in human lung fibroblasts.
ανά: Shi-wen, X, κ.ά.
Έκδοση: (2007)

OVERDENTURE IN SCLERODERMA'S PATIENT
ανά: , Elin Hertiana
Έκδοση: (2012)

GI Manifestation in Scleroderma
ανά: Chingching Foocharoen
Έκδοση: (2024-01-01)

Phaeochromocytoma Mimicking Scleroderma
ανά: Joan Joo-Ching Khoo, κ.ά.
Έκδοση: (2011-01-01)

Treatment for systemic scleroderma
ανά: Rezvaya Tairovich Alekperov, κ.ά.
Έκδοση: (2011-09-01)

Scleroderma and related disorders
ανά: Anupam Wakhlu, κ.ά.
Έκδοση: (2017-01-01)

Thelytoky in Scleroderma Immigrans
ανά: Clyde E. Keeler
Έκδοση: (1929-01-01)

Human otopathology in scleroderma
ανά: Melissa Castillo‐Bustamante, κ.ά.
Έκδοση: (2023-12-01)

Finger Printlessness in Scleroderma
ανά: Milad HOSSEINIALHASHEMI, κ.ά.
Έκδοση: (2016-08-01)

Scleroderma lung disease
ανά: Joshua J. Solomon, κ.ά.
Έκδοση: (2013-03-01)

Scleroderma renal crisis
ανά: Gioacchino Li Cavoli, κ.ά.
Έκδοση: (2018-01-01)

Purtscher’s retinopathy in scleroderma
ανά: Alzahrani, Mazen, κ.ά.
Έκδοση: (2019-03-01)

Treatment for systemic scleroderma
ανά: Rezvaya Tairovich Alekperov, κ.ά.
Έκδοση: (2011-09-01)

Localized scleroderma in children
ανά: Katarzyna A. Wolska-Gawron, κ.ά.
Έκδοση: (2020-06-01)

Scleroderma-related choroiditis
ανά: Parthopratim Dutta Majumder, κ.ά.
Έκδοση: (2018-01-01)

Single-Cell Analysis of ADSC Interactions with Fibroblasts and Endothelial Cells in Scleroderma Skin
ανά: Marvin L. Frommer, κ.ά.
Έκδοση: (2023-07-01)

Scleroderma of geriatric age and scleroderma-like paraneoplastic syndrome – description of two cases
ανά: Magdalena Marek, κ.ά.
Έκδοση: (2016-06-01)